The Biomarker Salivary SP-D May Indicate Small Airway Inflammation and Asthma Exacerbation

S Okazaki1, H Murai1, S Kidoguchi2

  • 1Department of Pediatrics, Faculty of Medial Sciences, University of Fukui, Fukui, Japan.

Insights

Salivary surfactant protein (SP) D is elevated in children with asthma and correlates with airway resistance and exacerbation severity. This finding suggests SP-D may be a useful noninvasive biomarker for childhood asthma management.

Area of Science:

  • Pediatric Pulmonology
  • Biomarker Discovery
  • Asthma Pathophysiology

Background:

  • Noninvasive, child-friendly biomarkers are crucial for understanding childhood asthma phenotypes.
  • Salivary surfactant protein (SP) D is explored as a potential biomarker.

Purpose of the Study:

  • To assess the utility of salivary SP-D in evaluating childhood asthma pathophysiology.
  • To correlate salivary SP-D levels with lung function and exacerbation severity.

Main Methods:

  • Salivary SP-D concentrations and forced oscillation technique (FOT) indexes were measured in 19 healthy controls and 21 asthmatic children.
  • Regression models for FOT indexes were derived from healthy controls.
  • Correlations between salivary SP-D and FOT predictive values, and exacerbation severity were analyzed.

Main Results:

  • Asthmatic children exhibited higher salivary SP-D levels compared to healthy controls.
  • In asthmatic children, salivary SP-D correlated with %R5-R20 (peripheral airway resistance).
  • Salivary SP-D levels also correlated with asthma exacerbation severity.

Conclusions:

  • Salivary SP-D may indicate asthmatic inflammation in peripheral small airways.
  • Salivary SP-D shows potential as a useful marker for monitoring childhood asthma exacerbation.
Abstract